Women in the menopausal transition and early postmenopause are at higher risk for depressive symptoms and negative mood than those in late postmenopause.
Menopausal status is associated with accelerated lung function decline.
The FDA recently approved Intrarosa (prasterone) for moderate to severe pain during sexual intercourse due to menopause.
The use of menopausal hormone therapy was associated with improved bone mineral density and better bone microarchitecture.
Half of women treated with acupuncture report a decline in the frequency of menopausal vasomotor symptoms, according to a study published in Menopause.
Although a majority of women reported sexual satisfaction, many felt that it could improve.
Many women are able to adapt to the negative changes in sexual function that they experience as they age.
After 10 years follow-up, researchers found that women who experienced surgical menopause were more likely to suffer worse insomnia symptoms.
Nearly 2000 women underwent screening to determine if a link exists between depression or depressive symptoms and coronary artery disease.
Both peri- and postmenopausal women were assessed to find a relationship between sleep time, sleep quality, and carotid atherosclerosis.